推薦產(chǎn)品
3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazole 2-(chloromethyl)-3-methylpyridinehydrochloride 1-(2-bromo-4-methylphenyl)ethanone 3-chloroisoquinoline-4-carbonitrile 5,8-dichloropyrido[3,2-d]pyridazine 2-bromomalononitrile 2-(4-(bromomethyl)phenyl)benzo[d]thiazole 1-(bromomethyl)-3-methoxy-2-nitrobenzene 6-bromo-1H-[1,2,3]triazolo[4,5-b]pyridine 4-iodo-2-((trimethylsilyloxy)methyl)thiazole 6-iodoimidazo[1,2-a]pyridine-3-carbonitrile 2-(4-chlorophenyl)-2-morpholinoacetonitrile 4-chloro-7H-pyrrolo[2,3-d]pyrimidine 4-chloroisothiazole 5-bromo-6-chloro-1H-indole 7-chloro-3H-imidazo[4,5-b]pyridine ethyl3-(4-formylphenyl)propanoate 2,3-dibromobenzaldehyde 1-(5H-chromeno[2,3-b]pyridin-7-yl)ethanone 5H-chromeno[2,3-b]pyridin-5-one 3-chloroisoquinoline-4-carbaldehyde (E)-2-(3-oxoprop-1-enyl)benzaldehyde methyl4-formyl-3-nitrobenzoate 5,6-dimethoxy-2,2-dimethyl-2,3-dihydro-1H-inden-1-one 1-methylbicyclo[4.1.0]heptan-3-one 3-nitro-4-(trifluoromethoxy)benzaldehyde 2-hydroxyquinoline-6-carbaldehyde 2-nitro-3-(trifluoromethyl)benzaldehyde 1-(2-fluoro-4-methoxyphenyl)propan-2-one tert-butyl3-fluoro-4-oxopiperidine-1-carboxylate tert-butyl3-oxopropylcarbamate 2,2-dimethylcyclohexanone 9H-carbazole-3-carbaldehyde N,N-dimethyl-2-oxoacetamide 2-methylpent-4-yn-2-ol 3-tert-butyl-4-hydroxybenzonitrile 4-bromo-2-tert-butylphenol 1,3-dibutoxypropan-2-ol methyl4-hydroxyquinoline-6-carboxylate methyl3-cyano-4-hydroxybenzoate 4-chloro-6-methoxyquinolin-7-ol 3,4-dihydro-2H-benzo[b][1,4]oxazin-7-ol 2-(2-aminothiazol-5-yl)ethanolhydrochloride (R)-ethyl2-chloropropanoate (S)-4-amino-5-(4,4-dimethylcyclohexylamino)-5-oxopentanoicacid (1s,4s)-4-hydroxycyclohexanecarboxylicacid (S)-2-(tetrahydrofuran-3-yloxy)aceticacid (1S,4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-enol (R)-4-(hydroxymethyl)oxazolidin-2-one (S)-4-(hydroxymethyl)oxazolidin-2-one 化工資訊 《中國(guó)藥典》一部主要收載中藥材、飲片、提取物和中成藥的質(zhì)量標(biāo)準(zhǔn)，也就是大家常說(shuō)的中藥標(biāo)準(zhǔn)。日前正式發(fā)行的《中國(guó)藥典》2015年版一部目錄中共收載藥材和飲片618個(gè)(不含收載在品種下的飲片標(biāo)準(zhǔn))、植物油脂和提取物47個(gè)、成方制劑和單味制劑1493個(gè)。較2010年版藥典，2015年版藥典的中藥標(biāo)準(zhǔn)在安全性、有效性等方面均有所提升。正如國(guó)家藥典委員會(huì)秘書(shū)長(zhǎng)張偉所說(shuō)的那樣：“藥典是引領(lǐng)產(chǎn)業(yè)結(jié)構(gòu)調(diào)整和產(chǎn)品質(zhì)量升級(jí)的‘導(dǎo)航儀’”。
由于中藥多數(shù)來(lái)源于天然物質(zhì)，不僅所含成分非常復(fù)雜，而且受氣候、生態(tài)環(huán)境、栽培(生產(chǎn))技術(shù)等因素影響很大。中藥質(zhì)量標(biāo)準(zhǔn)是隨著中藥所含成分的不斷闡明、對(duì)中藥安全性認(rèn)識(shí)的不斷提升，以及中藥市場(chǎng)出現(xiàn)的新問(wèn)題和現(xiàn)代分析方法的不斷出現(xiàn)而不斷提高的，因此每版藥典一部的標(biāo)準(zhǔn)水平都有較大程度的提升。據(jù)介紹，每一版藥典在開(kāi)始工作前，都需要成立新一屆藥典委員會(huì)，規(guī)劃新版藥典工作，并形成編制大綱。中藥的安全性、有效性和質(zhì)量可控性是《中國(guó)藥典》2015年版編制大綱的“規(guī)定動(dòng)作”。
